Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Bladder Dysfunction Reports
Published in: Current Bladder Dysfunction Reports 2/2018

01-06-2018 | BPH-Related Voiding Dysfunction (R Lee, Section Editor)

Prostate Artery Embolization: Current Status 2018

Authors: Jonathan Fainberg, Bilal Chughtai, Richard Lee, Alexis Te, Timothy McClure

Published in: Current Bladder Dysfunction Reports | Issue 2/2018

Login to get access

Abstract

Purpose of Review

Prostate artery embolization (PAE) is a promising new treatment option for men with symptomatic benign prostatic hyperplasia (BPH). Our goal is to review the data on PAE with regard to outcomes, risks versus benefits, and safety.

Recent Findings

Current data suggests that PAE is safe and effective for men with symptomatic BPH. The two most robust randomized controlled trials comparing PAE with TURP both found comparable short-term results with regard to improvements in symptoms. However, the side effects of PAE were higher than those of TURP. There remain ongoing randomized controlled trials comparing the two modalities of treatment.

Summary

Though the largest randomized controlled trials comparing these two modalities of treatment of BPH are still underway, current data suggest PAE may be a promising, safe, and effective treatment option for men with symptomatic BPH. Additionally, PAE can be safely performed on larger prostates of any size and is generally performed via a single, femoral artery puncture under local anesthesia. Therefore, it is particularly appealing for patients with prostate glands > 80 g and who are poor candidates for general anesthesia.
Literature
1.
2.
McVary KT. BPH: epidemiology and comorbidities. Am J Managed Care. 2006;12(5):S122–8.
3.
Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abriams P. The natural history of lower urinary tract dysfunction in men: minimum 10 year urodynamic follow up of transurethral resection of the prostate for bladder outlet obstruction. J Urol. 2005;174:1887–991.CrossRefPubMed
4.
Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and post operative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 2002;167:999–1003.CrossRefPubMed
5.
Mitchell ME, Waltman AC, Athanasoulis CA, Ken WS Jr, Dretler SP. Control of massive prostatic bleeding with angiographic techniques. J Urol 1976:115:692–695.
6.
Pereira K, Halpern JA, McClure TD, Lewis NA, Kably I, Bhatia S, et al. Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. BJU Int. 2016;118(3):359–65.CrossRefPubMed
7.
DeMerritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after trans-arterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol. 2000;11:767–70.CrossRef
8.
Michel F, Dubruille T, Cercueil JP, Paparel P, Cognet F, Krause D. Arterial embolization for massive hematuria following transurethral prostatectomy. J Urol. 2002;168:2550–1.CrossRefPubMed
9.
Sun F, Sanchez FM, Crisostomo V, et al. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment—preliminary study in pigs. Radiology. 2008;246(3):783–9.CrossRefPubMed
10.
Bilhim T, Tinto HR, Fernandes L, Martins Pisco J. Radiological anatomy of prostatic arteries. Tech Vasc Interv Radiol. 2012 Dec;15(4):276–85.CrossRefPubMed
11.
Mirakhur A, McWilliams J. Protate artery embolization for benign prostatic hyperplasia: current status. Can Assoc of Radiol J. 2017;68:84–9.CrossRef
12.
• Pisco JM, et al. Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol. 2016;27:1115–22. Highlights long term outcomes of PAE to > 6 years which few other papers have done.
13.
•• Gao YA, Huang Y, Zhang R, Yang YD, Zhang Q, Hou M, et al. Benign prostatic hypertrophy: prostate artery embolization vs. transurethral resection of the prostate, a prospective, randomized controlled trial. Vasc and Interventional Radiology. 2014;270(3):920–8. One of the few prospective, randomized controlled trials comparing PAE to TURP.
14.
•• Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Interv Radiol. 2013;37:1602–5. The only paper comparing TURP to PAE and Perfected PAE, which is a novel technique that allows for more complete embolization of the prostatic artery.
15.
Moreira AM, de Assis AM, Carnevale FC, Antunes AA, Srougi M, Cerri GG. A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH. Cardiovasc Intervent Radiol. 2017 Oct;40(10):1490–500.CrossRefPubMed
16.
Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Interv Radiol. 2013, 37:1602–5.
17.
Bagla S, Smirniotopoulos JB, Orlando JC, van Breda A, Vadlamudi V. Comparative analysis of prostate volume as a predictor of outcome in prostate artery embolization. J Vasc Interv Radiol. 2015;26:1832–8.CrossRefPubMed
18.
Bilhim T, Pisco JM, Rio Tinto H, Fernandes L, Campos Pinheiro L, Duarte M, et al. Unilateral vs. bilateral prostatic artery embolization for lower urinary tract symptoms in patients with prostate enlargement. Cardiovasc Intervent Radiol. 2013;36:403–11.CrossRefPubMed
Metadata
Title
Prostate Artery Embolization: Current Status 2018
Authors
Jonathan Fainberg
Bilal Chughtai
Richard Lee
Alexis Te
Timothy McClure
Publication date
01-06-2018
Publisher
Springer US
Published in
Current Bladder Dysfunction Reports / Issue 2/2018
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-018-0463-6

Other articles of this Issue 2/2018

Current Bladder Dysfunction Reports 2/2018 Go to the issue

Overactive Bladder (U Lee and S Adelstein, Section Editors)

Insight Into the Central Control of Overactive Bladder Symptoms by Functional Brain Imaging

Stress Incontinence and Prolapse (S Reynolds, Section Editor)

Stress Urinary Incontinence in Women with Neurogenic Lower Urinary Tract Dysfunction

Neurogenic Bladder (C Powell, Section Editor)

Urologic Applications of the Microbiota in Multiple Sclerosis

Overactive Bladder (U Lee and S Adelstein, Section Editors)

Trends in Utilization of Third-Line Therapies for Non-neurogenic Overactive Bladder: Sacral Neuromodulation, Peripheral Tibial Nerve Stimulation, and Intradetrusor OnabotulinumtoxinA

Pediatric Voiding Dysfunction (Douglas Clayton and John Thomas, Section Editors)

Non-invasive Testing and Its Role in Diagnosis and Management of Children With Voiding Dysfunction

Pediatric Voiding Dysfunction (Douglas Clayton and John Thomas, Section Editors)

The Role of Bowel Management in Children with Bladder and Bowel Dysfunction